|
Detailed information for selected cell line:
| Cell Line: |
RNJ19; congenital nephrotic syndrome mutation
|
| NIH Registration Number: |
0126
|
| NIH Approval Number: |
NIHhESC-11-0126
|
| Available for Distribution: |
Yes
|
| Provider Restrictions: |
No Restrictions
|
| Additional Information: |
This cell line was derived from an embryo that definitively carried the maternal mutation for congenital nephrotic syndrome; however, the status of the paternal mutation is unknown. The line could be either a compound heterozygote (positive for both the maternal and paternal mutations), or a simple heterozygote (positive for the maternal mutation and negative for the paternal mutation).
|
| NIH Restrictions: |
NIH-funded research with this line is limited to research consistent with the following language from the informed consent document: "...characterization of stem cells from embryos discarded due to genetic defects or other abnormalities and the development of new methods for transforming stem cells into other cell types."
|
| Submitting Organization: |
Reprogenetics, LLC |
| Provider Name: |
Reprogenetics, LLC
|
| Provider Phone: |
9733225043
|
| Provider Email: |
mina.alikani@embryos.net
|
| Provider URL: |
|
| Approval Date: |
06/16/2011 |
View All Lines Eligible for Use
Go to NIH Form 2890 Login Page
Go to NIH Stem Cell Information Page
| |
NIH Form 2890:
- Login
Page
(Authorization Required)
Contact Us:
- Email questions to:
hescregistry@mail.nih.gov
(Emails that are offensive or unrelated to stem cells will be
deleted.)
|
| |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
